State Street Corp Fulgent Genetics, Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, State Street Corp holds 513,797 shares of FLGT stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

513,797

Previous 506,785 1.38%

Holding current value

$10.8 Million

Previous $8.56 Million 19.27%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$16.86 - $21.81 $118,222 - $152,931	7,012 Added 1.38%	513,797 $10.2 Million
Q1 2025 May 15, 2025	SELL	$15.28 - $18.95 $4.78 Million - $5.92 Million	-312,637 Reduced 38.15%	506,785 $8.56 Million
Q4 2024 Feb 14, 2025	BUY	$16.71 - $22.68 $432,404 - $586,890	25,877 Added 3.26%	819,422 $15.1 Million
Q3 2024 Nov 14, 2024	BUY	$19.6 - $25.06 $213,012 - $272,352	10,868 Added 1.39%	793,545 $17.2 Million
Q2 2024 Aug 14, 2024	SELL	$19.09 - $22.57 $797,962 - $943,426	-41,800 Reduced 5.07%	782,677 $15.4 Million
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $248,794 - $338,153	11,545 Added 1.42%	824,477 $17.9 Million
Q4 2023 Feb 14, 2024	BUY	$23.64 - $30.27 $965,835 - $1.24 Million	40,856 Added 5.29%	812,932 $23.5 Million
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $425,567 - $649,491	15,915 Added 2.1%	772,076 $20.6 Million
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $1.22 Million - $1.75 Million	-42,920 Reduced 5.37%	756,161 $28 Million
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $205,553 - $253,672	-6,994 Reduced 0.87%	799,081 $24.9 Million
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $1.45 Million - $2 Million	49,718 Added 6.57%	806,075 $24 Million
Q3 2022 Nov 15, 2022	BUY	$37.92 - $63.74 $1.45 Million - $2.43 Million	38,121 Added 5.31%	756,357 $28.8 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $1.06 Million - $1.39 Million	22,153 Added 3.18%	718,236 $39.2 Million
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $3.53 Million - $6.8 Million	70,764 Added 11.32%	696,083 $43.4 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $291,266 - $395,640	3,768 Added 0.61%	625,319 $62.9 Million
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $926,291 - $1.37 Million	12,372 Added 2.03%	621,551 $55.9 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $10 Million - $15.1 Million	150,062 Added 32.68%	609,179 $56.2 Million
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $2.8 Million - $8.69 Million	47,260 Added 11.47%	459,117 $44.4 Million
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $4.53 Million - $7.62 Million	146,193 Added 55.03%	411,857 $21.5 Million
Q3 2020 Nov 10, 2020	BUY	$15.89 - $50.51 $2.08 Million - $6.61 Million	130,881 Added 97.1%	265,664 $10.6 Million
Q2 2020 Aug 14, 2020	BUY	$8.89 - $18.28 $1.2 Million - $2.46 Million	134,783 New	134,783 $2.16 Million

Others Institutions Holding FLGT

# of Institutions

188

Shares Held

18.3M

Call Options Held

185K

Put Options Held

24.8K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $636M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Fulgent Genetics, Inc. Transaction History